Arikan Abelló Fuat, Ley Urzaiz Luis, Fernández Alén José, Martín Láez Rubén
Unidad de Investigación de Neurotraumatología-Neurocirugía, Servicio de Neurocirugía, Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona, Hospital Universitario Vall d'Hebron, Barcelona, España.
Servicio de Neurocirugía,. Hospital Universitario Ramón y Cajal, Madrid, España.
Neurocirugia (Astur). 2017 Nov-Dec;28(6):284-293. doi: 10.1016/j.neucir.2017.08.001. Epub 2017 Oct 10.
The use of antithrombotic medication (antiplatelet and/or anticoagulant therapy) is widespread. Currently, the management of neurosurgical patients receiving this type of therapy continues to be a problem of special importance. Patients receiving antithrombotic treatment may need neurosurgical care because of bleeding secondary to such treatment, non-haemorrhagic neurosurgical lesions requiring urgent attention, or simply elective neurosurgical procedures. In addition, the consequences of reintroducing early (bleeding or rebleeding) or late (thrombotic or thromboembolic) anticoagulation can be devastating. In this paper we present the antithrombotic treatment consensus protocol during the perioperative and periprocedural period, both in emergent surgery and in elective neurosurgical procedures.
抗血栓药物(抗血小板和/或抗凝治疗)的使用非常广泛。目前,接受此类治疗的神经外科患者的管理仍然是一个特别重要的问题。接受抗血栓治疗的患者可能由于此类治疗继发的出血、需要紧急处理的非出血性神经外科病变或仅仅是择期神经外科手术而需要神经外科护理。此外,过早(出血或再出血)或过晚(血栓形成或血栓栓塞)重新开始抗凝的后果可能是灾难性的。在本文中,我们提出了围手术期和围操作期在急诊手术和择期神经外科手术中的抗血栓治疗共识方案。